GCP
ASLN

GSA Capital Partners’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

GSA Capital Partners’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,984
Closed -$89K – 1926
2021
Q4 		$89K Buy
+1,984
New +$119K 0.01% 1320

Other funds holding ASLN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

GSA Capital Partners's ASLN Position: Q1 2022 in Review

GSA Capital Partners sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2022, closing a stake of 1,984 shares — an estimated $89K sold.

GSA Capital Partners first reported a position in ASLN in Q4 2021 and held it in 1 quarter. The position peaked at $89K in Q4 2021. 31 funds tracked by Wall St. Rank hold ASLN as of Q1 2022.

  • GSA Capital Partners reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • GSA Capital Partners sold 1,984 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2022, an estimated $89K.
  • GSA Capital Partners first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • GSA Capital Partners's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $89K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2022.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.